Myasthenia gravis: vizsgálatok itt: Ausztria
5 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 2/3. fázisCsak meghívásosEvaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
- Where
- Vienna
- Életkor
- 2 év to 18 év
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT05374590 · EU 2023-507379-23-00 - 3. fázisTaking peopleComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Where
- Vienna
- Életkor
- 18 év to 74 év
- People
- 115 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07217587 · EU 2025-521130-28-00 - 3. fázisTaking peopleA Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Where
- Linz, Salzburg, Schwarzach Im Pongau, Wels
- Életkor
- 18 év to 80 év
- People
- 195 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00 - No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341 - No phaseTaking peopleA Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Where
- Linz
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- argenx
See details and how to joinNCT06298565